ERO1-Like Alpha is thought to be an oxidoreductase involved in disulfide bond formation in the endoplasmic reticulum.
| Inventor | Institute |
|---|---|
| Ayham Alnabulsi | Vertebrate Antibodies Limited |
| Cat. #: | 152704 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell signaling and signal transduction;Genetics;Metabolism |
| Application: | ELISA ; IHC ; WB |
| Target: | ERO1-like (ERO1-Like-Alpha) |
| Reactivity: | Dog ; Horse ; Human ; Mouse ; Pig ; Rat ; Sheep |
| Clone: | V23P3C9*H2 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | ERO1-Like Alpha is thought to be an oxidoreductase involved in disulfide bond formation in the endoplasmic reticulum. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG1 kappa |
| Immunogen: | Peptide Sequence KLIANMPESG (peptide immunogen is identical in rat (Rattus norvegicus), mouse (Mus musculus), sheep (Ovis aries), cow (Bos taurus), dog (Canis familiaris), pig (Sus scrofa) and horse (Equus caballus) |
| Myeloma used: | P3X63Ag8.653 |
| Target background: | ERO1-Like Alpha is thought to be an oxidoreductase involved in disulfide bond formation in the endoplasmic reticulum. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151028 | Anti-Cytochrome P450 2C2, 2B1/2 [h7] |
Key Info
Anti-Cytochrome P450 2C2, 2B1/2 [h7]
|
View Tool | |||||||||||||||||||
| 151034 | Anti-HSVUL42 [13D11] |
Key Info
Anti-HSVUL42 [13D11]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.